Skip to main content
All lobbying clients

SAREPTA THERAPEUTICS

Lobbying client · Massachusetts · filed 2025 to 2026

A biopharmaceutical company focused on innovative RNA-based therapeutics

$2,910,000 Reported spend
20 Filings counted
2 Outside firms hired
2 Bills named

Spend is reported income plus in-house expenses across 20 filings. 2 further filings for this client were restated by a later amendment and are left out of every total here. The LDA keeps a separate client record for every registrant that files for a client, so this page adds up 3 records, one per registrant listed below. Records are combined when the client name matches once case, punctuation and endings such as Inc. or LLC are set aside; for a city, county or port the state has to match as well. These filings have also been reported as SAREPTA THERAPEUTICS, INC.

 Who filed for this client 3

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

 Bills named in these filings 2
  • H.R. 9260
    Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
    2 filings
  • H.R. 1509
    Accelerating Kids’ Access to Care Act of 2025
    1 filing
 Reported by year 2 years
  • 2026 $1,080,000 8 filings
  • 2025 $1,830,000 12 filings
 Issues lobbied 8

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 4
  • HOUSE OF REPRESENTATIVES 19
  • SENATE 19
  • Health & Human Services, Dept of (HHS) 6
  • Executive Office of the President (EOP) 5
 Recent filings 22 total
Q3 report
TARPLIN, DOWNS & YOUNG, LLC
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $90,000 income · posted Oct 20, 2026
View → Q3 report
SAREPTA THERAPEUTICS, INC.
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $160,000 expenses · posted Oct 19, 2026
View → Q2 termination
MICHAEL BEST STRATEGIES LLC
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $50,000 income · posted Jul 20, 2026
View → Q2 report
TARPLIN, DOWNS & YOUNG, LLC
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $90,000 income · posted Jul 20, 2026
View → Q2 report
SAREPTA THERAPEUTICS, INC.
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $220,000 expenses · posted Jul 20, 2026
View → Q1 report
MICHAEL BEST STRATEGIES LLC
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $110,000 income · posted Apr 20, 2026
View → Q1 report
SAREPTA THERAPEUTICS, INC.
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $270,000 expenses · posted Apr 20, 2026
View → Q1 report
TARPLIN, DOWNS & YOUNG, LLC
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $90,000 income · posted Apr 20, 2026
View → Q4 amendment
TARPLIN, DOWNS & YOUNG, LLC
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $90,000 income · posted Jan 20, 2026
View → Q4 amendment
TARPLIN, DOWNS & YOUNG, LLC Amended
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $90,000 income · posted Jan 20, 2026
View → Q4 report
TARPLIN, DOWNS & YOUNG, LLC Amended
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $90,000 income · posted Jan 20, 2026
View → Q4 report
MICHAEL BEST STRATEGIES LLC
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $110,000 income · posted Jan 20, 2026
View → Q4 report
SAREPTA THERAPEUTICS, INC.
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $230,000 expenses · posted Jan 20, 2026
View → Q3 report
MICHAEL BEST STRATEGIES LLC
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $110,000 income · posted Oct 20, 2025
View → Q3 report
TARPLIN, DOWNS & YOUNG, LLC
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $80,000 income · posted Oct 20, 2025
View → Q3 report
SAREPTA THERAPEUTICS, INC.
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $430,000 expenses · posted Oct 15, 2025
View → Q2 report
MICHAEL BEST STRATEGIES LLC
2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $40,000 income · posted Jul 21, 2025
View → Q2 report
TARPLIN, DOWNS & YOUNG, LLC
2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $80,000 income · posted Jul 21, 2025
View → Q2 report
SAREPTA THERAPEUTICS, INC.
2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $260,000 expenses · posted Jul 16, 2025
View → Registration
MICHAEL BEST STRATEGIES LLC
2nd Quarter 2025 (Apr 1 - June 30) · posted Jul 15, 2025
View →

Showing the 20 most recent of 22 filings. Search the explorer for "SAREPTA THERAPEUTICS".

Keep going

Filings through , the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem